Cross-sectional Hospital-based Investigation on Clinical Characteristics of Pediatric Staphylococcus aureus Isolates

LuWei Wang1, Jing-Hui Zhen1, Fang Dong1

  • 1Department of Clinical Laboratory Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China.

PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is a growing concern in children, with high resistance rates to common antibiotics like penicillin and erythromycin observed in Beijing. Ongoing surveillance and revised treatment guidelines are crucial to combatting its spread.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Staphylococcus aureus (S. aureus) is a common pathogen in children, with increasing antibiotic resistance.
  • Methicillin-resistant Staphylococcus aureus (MRSA) has become a significant cause of healthcare-associated and community-acquired infections globally.
  • Antimicrobial resistance patterns of S. aureus in pediatric populations require continuous monitoring.

Purpose of the Study:

  • To analyze the prevalence and antimicrobial resistance patterns of S. aureus infections in children in Beijing, China.
  • To highlight the significance of S. aureus as a pediatric pathogen.
  • To provide data for revising clinical treatment guidelines.

Main Methods:

  • Retrospective analysis of S. aureus isolates from 2013-2022 at Beijing Children's Hospital.
  • Antimicrobial susceptibility testing using Vitek 2 automated system or Kirby-Bauer disc diffusion.
  • Analysis of patient demographics, specimen sources, and isolate resistance profiles.

Main Results:

  • S. aureus was identified in 6477 isolates from 433,081 specimens.
  • Infants under one year old accounted for the majority of S. aureus infections (37.9%).
  • High resistance rates were observed for penicillin (89.5%) and erythromycin (73.8%), while low rates were seen for linezolid and vancomycin (0.0%).
  • The MRSA detection rate was 27.8%, with higher prevalence in newborns, ICUs, and sterile body fluids.
  • Lower respiratory tract specimens were most common, but ear secretions showed the highest positive rate.

Conclusions:

  • S. aureus remains a significant pathogen in children, with notable antimicrobial resistance.
  • Elevated MRSA rates in vulnerable populations necessitate updated treatment guidelines and surveillance.
  • Targeted interventions are essential to mitigate the spread of antimicrobial-resistant S. aureus.
Abstract

Related Concept Videos

Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...